Patents by Inventor David G. Maggs

David G. Maggs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INSULIN-PRAMLINTIDE COMPOSITIONS AND METHODS FOR MAKING AND USING THEM
    Publication number: 20150174209
    Abstract: In alternative embodiments, the invention provides formulations, pharmaceutical compositions, devices and other products of manufacture comprising a therapeutically effective mixture of an insulin and a pramlintide, and methods for making and using them.
    Type: Application
    Filed: May 24, 2013
    Publication date: June 25, 2015
    Applicants: AMYLIN PHARMACEUTICALS. LLC, UVA PATENT FOUNDATION d/b/a THE UVA LICENSING AND VENTURES GROUP, GRUPPO BIOMED MOD
    Inventors: Elaine Chiquette, Kathrin Herrmann, David G. Maggs, Orville G. Kolterman, Jui-Chen Lin, Steven Shijun Ren, Li Jin, Claudio Cobelli, Boris Kovatchev
  • Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Patent number: 8389472
    Abstract: The present invention relates generally to the novel use of incretin compounds (ICs) and amylinomimetic compounds to treat, prevent, or ameliorate a variety of metabolic conditions or diseases.
    Type: Grant
    Filed: August 21, 2006
    Date of Patent: March 5, 2013
    Assignees: Amylin Pharmaceuticals, LLC, AstraZeneca Pharmaceuticals LP
    Inventors: Alain D. Baron, Dennis Kim, David G. Maggs, Matthew Wintle
  • Uses of Glucoregulatory Proteins
    Publication number: 20090312246
    Abstract: The present invention relates generally to the novel use of incretin compounds (ICs) and amylinomimetic compounds to treat, prevent, or ameliorate a variety of metabolic conditions or diseases.
    Type: Application
    Filed: August 21, 2006
    Publication date: December 17, 2009
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Alain D. Baron, Dennis Kim, David G. Maggs, Matthew Wintle
  • Use of amylin agonists to modulate triglycerides
    Publication number: 20030130177
    Abstract: Methods of improving lipid profile, including methods for lowering fasting triglyceride levels and post-prandial triglyceride excursions are disclosed comprising administering an effective amount of an amylin or amylin agonist.
    Type: Application
    Filed: January 8, 2003
    Publication date: July 10, 2003
    Inventors: Orville G. Kolterman, Christian Weyer, David G. Maggs, Mark Fineman